NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT00424723 2010-08-12Pemetrexed in Patients With Advanced Neuroendocrine TumorsDana-Farber Cancer InstitutePhase 2 Completed32 enrolled